Search
for

    Sort by

    Research 931–960 of 1000+

    1. Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases JAAD Case Reports · 2024
    2. Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials JEADV Clinical Practice · 2024
    3. Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients Australasian Journal of Dermatology · 2024
    4. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024
    5. Gene-Environment Interaction Between <i>CYP1B1</i> and Oral Contraception on Frontal Fibrosing Alopecia JAMA Dermatology · 2024
    6. Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata JEADV Clinical Practice · 2024
    7. Scalp trauma in lichen planopilaris: Case reports of disease progression from fire fighter helmet use JAAD Case Reports · 2024
    8. Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations Cosmetics · 2024
    9. Lichen planopilaris in 24 African American women International Journal of Women’s Dermatology · 2024
    10. Validation of alopecia coding in US claims data among women of childbearing age Pharmacoepidemiology and drug safety (Print) · 2024
    11. The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016 Dermatology and therapy · 2024
    12. Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights Journal of Investigative Dermatology · 2024
    13. Combating “Dread Shed”: The Impact of Overlapping Topical and Oral Minoxidil on Temporary Hair Shedding During Oral Minoxidil Initiation JAAD International · 2024
    14. Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries Dermatology and therapy · 2024
    15. Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    16. Clinical and sociodemographic features of alopecia areata in five Colombian cities: an analysis of the RENAAC registry 2024
    17. Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología Actas Dermo-Sifiliográficas · 2024
    18. Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer Cancers · 2024
    19. PCSK9: From Nature’s Loss to Patient’s Gain Circulation · 2024
    20. Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial JEADV clinical practice · 2024
    21. Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia JEADV clinical practice · 2024
    22. Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs JEADV Clinical Practice · 2024
    23. Minoxidil: effectiveness and prospects for use in the treatment of androgenetic alopecia Farmateka · 2023
    24. Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment Journal of dermatology · 2023
    25. Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey Dermatology and therapy · 2023
    26. Teledermatology in Alopecia: A Systematic Review JAAD international · 2023
    27. Wait times and health care utilization among refugee patients in dermatology: A retrospective chart review Journal of the American Academy of Dermatology · 2023
    28. Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata Dermatology and Therapy · 2023
    29. Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia Expert Opinion on Pharmacotherapy · 2023
    30. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials JEADV Clinical Practice · 2023